232 related articles for article (PubMed ID: 8257827)
21. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
22. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor.
Muzzioli M; Stecconi R; Donnini A; Re F; Provinciali M
Int J Biochem Cell Biol; 2007; 39(5):955-65. PubMed ID: 17306601
[TBL] [Abstract][Full Text] [Related]
23. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
[TBL] [Abstract][Full Text] [Related]
24. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay.
Theunissen K; Verfaillie CM
Exp Hematol; 2005 Feb; 33(2):165-72. PubMed ID: 15676210
[TBL] [Abstract][Full Text] [Related]
25. Generation of natural killer cells from long-term cultures of mouse bone marrow.
Vecchini F; Delfino D; Patrene KD; DeLeo A; Lu L; Herberman RB; Boggs SS
Nat Immun; 1993; 12(1):1-16. PubMed ID: 8431659
[TBL] [Abstract][Full Text] [Related]
26. CD16+ CD56- NK cells in the peripheral blood of cord blood transplant recipients: a unique subset of NK cells possibly associated with graft-versus-leukemia effect.
Lu X; Kondo Y; Takamatsu H; Ohata K; Yamazaki H; Takami A; Akatsuka Y; Nakao S
Eur J Haematol; 2008 Jul; 81(1):18-25. PubMed ID: 18363874
[TBL] [Abstract][Full Text] [Related]
27. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion.
Silva MR; Parreira A; Ascensão JL
Exp Hematol; 1995 Dec; 23(14):1676-81. PubMed ID: 8542964
[TBL] [Abstract][Full Text] [Related]
28. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
Lotzová E; Savary CA; Herberman RB
J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic and cytolytic activity of Macaca nemestrina natural killer cells isolated from blood and expanded in vitro.
Shields LE; Sieverkropp AJ; Potter J; Andrews RG
Am J Primatol; 2006 Aug; 68(8):753-64. PubMed ID: 16847969
[TBL] [Abstract][Full Text] [Related]
30. Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3.
Kalland T
J Immunol; 1987 Dec; 139(11):3671-5. PubMed ID: 3500227
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC
Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic origin of human natural killer (NK) cells: generation from immature progenitors.
Silva MR; Kessler S; Ascensao JL
Pathobiology; 1993; 61(5-6):247-55. PubMed ID: 7507682
[TBL] [Abstract][Full Text] [Related]
33. Human thymic stroma supports human natural killer (NK) cell development from immature progenitors.
Vaz F; Srour EF; Almeida-Porada G; Ascensao JL
Cell Immunol; 1998 Jun; 186(2):133-9. PubMed ID: 9665755
[TBL] [Abstract][Full Text] [Related]
34. Natural killer (NK) cell generation in bone marrow cultures: role of IL-1 alpha.
Ayroldi E; Cannarile L; Riccardi C
Immunopharmacol Immunotoxicol; 1991; 13(4):589-606. PubMed ID: 1774437
[TBL] [Abstract][Full Text] [Related]
35. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cells generated from bone marrow culture.
Koo GC; Peppard JR; Mark WH
J Immunol; 1984 May; 132(5):2300-4. PubMed ID: 6201540
[TBL] [Abstract][Full Text] [Related]
37. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
Klingemann HG; Deal H; Reid D; Eaves CJ
Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
[TBL] [Abstract][Full Text] [Related]
38. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
Huang S; Chen Z; Yu JF; Young D; Bashey A; Ho AD; Law P
Stem Cells; 1999; 17(5):265-72. PubMed ID: 10527461
[TBL] [Abstract][Full Text] [Related]
39. Production and differentiation of NK linkage cells in bone marrow.
Pollack SB
Nat Immun; 1993; 12(4-5):177-93. PubMed ID: 8257825
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
